Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma

BackgroundPleural mesothelioma (PM) is a rare cancer with a dismal prognosis. Dual immune checkpoint inhibitors have improved overall survival, but the rate of immune-related adverse events (irAEs) is high. Serum cytokines reflect systemic immune reactions and may serve as biomarkers for irAEs.Patie...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Saima Jamil Farooqi, Zhi Zhao, Åsa Kristina Öjlert, Solfrid Thunold, Hedvig Vidarsdotter Juul, Maria Moksnes Bjaanæs, Henrik Horndalsveen, Hanne Marte Gjertsen Nymoen, Åslaug Helland, Vilde Drageset Haakensen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Subjects:	pleural mesothelioma immunotherapy biomarkers cytokines checkpoint inhibition blockade
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1480183/full

Similar Items

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
by: Christian Wilhelm Langberg, et al.
Published: (2023-07-01)

Thoracic radiation in combination with erlotinib—results from a phase 2 randomized trial
by: Hanne Marte Nymoen, et al.
Published: (2024-08-01)

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab
by: Henrik Horndalsveen, et al.
Published: (2025-10-01)

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
by: Henrik Horndalsveen, et al.
Published: (2023-03-01)

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
by: Åsa Kristina Öjlert, et al.
Published: (2021-11-01)

Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer
by: Maria Moksnes Bjaanæs, et al.
Published: (2021-04-01)

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
by: Åsa Kristina Öjlert, et al.
Published: (2019-05-01)

N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome
by: Thilde Terkelsen, et al.
Published: (2018-06-01)

Targeting lung cancer through inhibition of checkpoint kinases
by: Randi Gussgard Syljuåsen, et al.
Published: (2015-02-01)

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
by: Sólrún Melkorka Maggadóttir, et al.
Published: (2022-11-01)

COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
by: Tom Børge Johannesen, et al.
Published: (2021-03-01)

Monitorering og reversering av nevromuskulær blokade ved generell anestesi – en tverrsnittsundersøkelse av anestesipersonells praksis og vurderinger
by: Sigrunn Drageset, et al.
Published: (2023-05-01)

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
by: Janna Berg, et al.
Published: (2021-05-01)

Oral language skills and mental health in female prisoners: pragmatic skills are essential
by: Frøydis Morken, et al.
Published: (2023-07-01)

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
by: Janna Berg, et al.
Published: (2022-07-01)

Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
by: Janna Berg, et al.
Published: (2022-10-01)

Gravspråk i et fjordlandskap
by: Anne Drageset
Published: (2020-01-01)

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
by: Thilde Terkelsen, et al.
Published: (2021-02-01)

EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort study
by: Åslaug Helland, et al.
Published: (2024-01-01)

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare
by: Elisa Bjørgo, et al.
Published: (2024-06-01)

Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
by: Azadeh Abravan, et al.
Published: (2017-06-01)

EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway – A nationwide retrospective cohort study
by: Åslaug Helland, et al.
Published: (2022-01-01)

Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study
by: Johanne Elise Nyen, et al.
Published: (2025-03-01)

Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study
by: Johanne Elise Nyen, et al.
Published: (2025-02-01)

Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
by: Haiyan Dai, et al.
Published: (2001-01-01)

A 10‐year prediagnostic follow‐up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
by: Sinan Uğur Umu, et al.
Published: (2020-02-01)

Forståelse av kvantitativ helseforskning - en introduksjon og oversikt
by: Sigrunn Drageset, et al.
Published: (2009-02-01)

Mixed Methods Designs: vitenskapsteoretiske posisjoner – muligheter og utfordringer
by: Kari Røykenes, et al.
Published: (2024-04-01)

Distribution and characteristics of malignant tumours by lung lobe
by: Yngvar Nilssen, et al.
Published: (2024-03-01)

Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.
by: Oddmund Nordgård, et al.
Published: (2013-01-01)

The characterization of Helicobacter pylori DNA associated with ancient human remains recovered from a Canadian glacier.
by: Treena Swanston, et al.
Published: (2011-02-01)

Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway
by: Steinar Solberg, et al.
Published: (2025-10-01)

Analysis and comparison of the pan-genomic properties of sixteen well-characterized bacterial genera
by: Ziola Barry, et al.
Published: (2010-10-01)

Personer med demenssykdom i sykehjem: Refleksjon over livet
by: Ingrid Drageset, et al.
Published: (2013-06-01)

Familie og kontinuitet: Pårørende forteller om livsløpet til personer med demenssykdom
by: Ingrid Drageset, et al.
Published: (2012-06-01)

Health-related quality of life among cognitively intact nursing home residents with and without cancer – a 6-year longitudinal study
by: Drageset J, et al.
Published: (2017-04-01)

Better health-related quality of life (mental component summary), having a higher level of education, and being less than 75 years of age are predictors of hospital admission among cognitively intact nursing home residents: a 5-year follow-up study
by: Drageset J, et al.
Published: (2016-03-01)

Crucial aspects promoting meaning and purpose in life: perceptions of nursing home residents
by: Jorunn Drageset, et al.
Published: (2017-10-01)

Explaining State Adjudication Choices: Limits on Focusing on Visible Processes
by: Áslaug Ásgeirsdóttir
Published: (2021-01-01)

Forskande praksis i barnelitteraturfeltet: Stian Holes poetikk
by: Aslaug Nyrnes
Published: (2011-02-01)